Exagen Inc. (XGN)

Exagen Inc. (XGN) Q2 2021 Earnings Call Transcript
Aug. 10, 2021 | Price: Free! | Source: Motley Fool

Exagen, Inc. (XGN) CEO Ron Rocca on Q2 2021 Results - Earnings Call Transcript
Aug. 10, 2021 | Price: Free! | Source: Seeking Alpha

Exagen Inc. (XGN) CEO Ron Rocca on Q1 2021 Results - Earnings Call Transcript
May 12, 2021 | Price: Free! | Source: Seeking Alpha

Exagen Inc. (XGN) Q1 2021 Earnings Call Transcript
May 11, 2021 | Price: Free! | Source: Motley Fool

Exagen Inc. (XGN) CEO Ron Rocca on Q4 2020 Results - Earnings Call Transcript
March 17, 2021 | Price: Free! | Source: Seeking Alpha

Exagen Inc. (XGN) Q4 2020 Earnings Call Transcript
March 16, 2021 | Price: Free! | Source: Motley Fool

Recent filings

Exagen Inc. director just picked up 1,000 shares - Sept. 7, 2021

Entry into a Material Definitive - Aug. 27, 2021

Exagen Inc. Just Filed Its Quarterly Report: Net Loss Per ShareBa... - Aug. 9, 2021

Exagen Inc. Reports Second Quarter 2021 Results - Aug. 9, 2021

Exagen Inc. director just disposed of 6,800 shares - Aug. 6, 2021

Exagen Inc. director just disposed of 8,200 shares - Aug. 4, 2021

Exagen Inc. director was just granted 15,000 options - July 30, 2021

Exagen Inc. director just declared 0 ownership of the company. - July 30, 2021

Exagen Appoints Ana Hooker To Board Of Directors - July 30, 2021

Statement of changes in beneficial ownership of securities - June 29, 2021

Exagen Inc. director was just granted 9,000 options - June 21, 2021

Submission of Matters to a Vote of Security - June 21, 2021

Exagen Inc. director just declared 0 ownership of the company. - June 21, 2021

Statement of changes in beneficial ownership of securities - June 21, 2021

Statement of changes in beneficial ownership of securities - June 21, 2021

Exagen Inc. director was just granted 9,000 options - June 21, 2021

Major owner of Exagen Inc. was just granted 9,000 options - June 21, 2021

Statement of changes in beneficial ownership of securities - June 21, 2021

Statement of changes in beneficial ownership of securities - June 21, 2021

Exagen Inc.'s Chief Operating Officer just picked up 1,934 shares - May 17, 2021

Exagen Inc. Reports First Quarter 2021 Results - May 11, 2021

Securities to be offered to employees in employee benefit plans - May 11, 2021

Exagen Inc. Just Filed Its Quarterly Report: Net Loss Per ShareBa... - May 11, 2021

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 27, 2021

Exagen Inc. releases salary data. CEO sees compensation rise 73% - April 27, 2021

Statement of acquisition of beneficial ownership by individuals - April 9, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - April 1, 2021

Exagen Inc.'s Chief Operating Officer just declared owning 37,500 shares of Exagen Inc. - March 25, 2021

Exagen Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 23, 2021

Exagen Inc. Announces Proposed Public Offering Of Common Stock - March 23, 2021

Amendments to Articles of Incorporation or - March 22, 2021

Exagen Inc. just filed a prospectus, suggesting it plans to soon issue some securities - March 22, 2021

Exagen Inc. Reports Fourth Quarter And Full Year 2020 Results - March 16, 2021

Annual report [Section 13 and 15(d), not S-K Item 405] - March 16, 2021

Exagen Inc.'s Chief Medical Officer just picked up 37,500 shares - Feb. 25, 2021

Exagen Inc.'s Chief Financial Officer just picked up 37,500 shares - Feb. 25, 2021

Exagen Inc.'s President and CEO just picked up 50,000 shares - Feb. 25, 2021

Sami Mnaymneh just provided an update on activist position in Exagen Inc. - Feb. 24, 2021

Woody L. Hunt just provided an update on share ownership of Exagen Inc. - Feb. 16, 2021

Roderick just provided an update on share ownership of Exagen Inc. - Feb. 12, 2021

Sun Mountain Capital Partners, L.L.C. just provided an update on share ownership of Exagen Inc. - Feb. 11, 2021

Statement of acquisition of beneficial ownership by individuals - Feb. 11, 2021

Major owner of Exagen Inc. just disposed of 3,000 shares - Feb. 8, 2021

Major owner of Exagen Inc. just disposed of 51,667 shares - Jan. 26, 2021

Major owner of Lexagene Hldgs Inc. just disposed of 110,000 shares - Jan. 21, 2021

Major owner of Lexagene Hldgs Inc. just disposed of 1,271 shares - Jan. 20, 2021

Major owner of Lexagene Hldgs Inc. just disposed of 5,729 shares - Jan. 15, 2021

Major owner of Lexagene Hldgs Inc. just disposed of 15,000 shares - Jan. 14, 2021

LexaGene Initiates Program to Identify UK and South African COVID Sequences - Jan. 13, 2021

Lexagene Hldgs: Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results - Jan. 11, 2021

Major owner of Lexagene Hldgs Inc. just disposed of 32,580 shares - Jan. 11, 2021

Entry into a Material Definitive - Dec. 28, 2020

Major owner of Lexagene Hldgs Inc. just disposed of 125,000 shares - Dec. 16, 2020

Major owner of Lexagene Hldgs Inc. just disposed of 12,000 shares - Dec. 15, 2020

Major owner of Lexagene Hldgs Inc. just disposed of 17,500 shares - Dec. 14, 2020

Sorry, no schedule available for this company

Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference - Sept. 13, 2021

Exagen Inc. Reports Second Quarter 2021 Results - Aug. 9, 2021

Exagen Appoints Ana Hooker to Board of Directors - July 30, 2021

Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference - July 29, 2021

Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021 - July 26, 2021

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions - July 13, 2021

Exagen Elects Frank Stokes to Board of Directors - June 18, 2021

Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference - May 24, 2021

Exagen Inc. Reports First Quarter 2021 Results - May 11, 2021

Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests - May 4, 2021

Exagen Announces New Campaign and Initiatives for Lupus Awareness Month - May 3, 2021

Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021 - April 27, 2021

Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases - March 29, 2021

Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - March 25, 2021

Exagen Inc. Announces Pricing of Public Offering of Common Stock - March 22, 2021

Exagen Inc. Announces Proposed Public Offering of Common Stock - March 22, 2021

Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results - March 16, 2021

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021 - March 2, 2021

Exagen Inc. to Participate in the Cowen 41st Annual Health Care Conference - Feb. 22, 2021

Exagen Inc. To Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Feb. 3, 2021

 


Feedback